| |
Mean cell count/visual field (95% CI)
|
Cell type
|
Measurement at:
|
n
|
Omeprazole
| |
n
|
Placebo
|
Total endocrine cells (chromogranin) | Baseline | 88 | 22 (18.7, 25.3) | | 78 | 23 (19.2, 26.8) |
| End initial healing | 138 | 23 (20.5, 25.5) | | 140 | 24 (21.4, 26.7) |
| End first maintenance | 103 | 19 (16.9, 21.1) | | 82 | 19 (16.2, 21.8) |
Serotonin | Baseline | 86 | 1.2 (0.9, 1.5) | | 77 | 1.4 (1.1, 1.7) |
| End initial healing | 140 | 1.0 (0.8, 1.2) | | 140 | 1.0 (0.83, 1.17) |
| End first maintenance | 103 | 0.8 (0.65, 0.95) | | 82 | 0.9 (0.71, 1.09) |
Somatostatin | Baseline | 87 | 2.9 (2.3, 3.5) | | 77 | 3.5 (2.7, 4.3) |
| End initial healing | 140 | 2.8 (2.4, 3.2) | | 140 | 3.0 (2.5, 3.5) |
| End first maintenance | 103 | 2.4 (2.1, 2.8) | | 82 | 2.7 (2.3, 3.1) |